Skip to main content

Table 4 Prominent conditions by cluster in SAIL

From: The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function

SAIL

eGFR category

Cluster number

n

% of eGFR category

Cluster (defined via prominent condition(s))

15

1

1656

38.2

No prominent condition

5

608

14.0

Depression

8

519

12.0

No prominent condition

2

452

10.4

Cancer

4

357

8.2

Cancer

3

294

6.8

Heart failure, atrial fibrillation and pulmonary disease

6

289

6.7

Constipation

7

159

3.7

MI, heart failure and stroke

30

4

7065

28.9

No prominent condition

3

5452

22.3

Diabetes

2

5197

21.3

Chronic pain

1

3212

13.2

MI and heart failure

5

2614

10.7

Heart failure and atrial fibrillation

6

872

3.6

Depression, chronic pain and stroke

45

2

40,000

58.8

No prominent condition

1

10,056

14.8

Cancer

3

6990

10.3

Asthma and pulmonary disease

4

5391

7.9

Diabetes, heart failure and atrial fibrillation

5

3123

4.6

Chronic pain, constipation and stroke

6

2476

3.6

Chronic pain, constipation and depression

60

3

66,079

51.2

No prominent condition

1

29,274

22.7

Chronic pain

2

12,383

9.6

Pulmonary disease, asthma and diabetes

4

8486

6.6

Depression

5

7918

6.1

Diabetes and depression

6

2310

1.8

Pulmonary disease, depression and asthma

7

2724

2.1

MI, atrial fibrillation and heart failure

75

1

99,957

47.0

No prominent condition

2

84,041

41.2

No prominent condition

5

11,278

5.5

Cancer

4

9023

4.4

Chronic pain, asthma and pulmonary disease

3

3754

1.8

Pulmonary disease, cancer and asthma

90

1

136,801

63.7

No prominent condition

4

54,820

25.5

Hypertension

2

16,909

7.9

Hypertension, depression and chronic pain

5

4119

1.9

Cancer, depression and chronic pain

3

2149

1.0

Stroke, hypertension and chronic pain